New Strategies for Individualizing Treatment in DME
Luis A. Gonzalez, MD, MPH
Jeremiah Brown Jr., MD, MS, FASRS
SunRISe-1: 1-Year Durability and Patient-Reported Outcomes Results
First Results From Cohort 4 of the SunRISe-1 Trial
Revolutionizing Diagnostic Precision: AI-Driven Approaches in Digital Pathology and HER2 Expression
Marilyn Yuanxin Ma Bui, MD, PhD
Anne Vincent-Salomon, MD
Living with gMG: Navigating Personal, Professional, and Mental Health Challenges
Vera Bril, MD
Nicholas J. Silvestri, MD
Diagnostic Advances in gMG: Effective Tools and Techniques
Hans Katzberg, MD
Treatment Advances in Generalized Myasthenia Gravis: Addressing the Nuances of its Underlying Immunopathology
Autoantibodies Explained: Anti-AChR, Anti-MuSK, and Their Diagnostic Role
Traditional MG Treatments: Balancing Benefits, Risks, and Side Effect Management
Treatment Advances in Generalized Myasthenia Gravis: Clinical and Laboratory Criteria for Diagnosis and Optimal Treatment Selection
Jonathan Strober, MD
New Frontiers in MG: How FcRn Antagonists Are Changing MG Therapy
A Scientific Look at FcRn Antagonists: Mechanisms of Action Explained
Managing Side Effects in FcRn Therapy: Best Practices for gMG
What’s New in Schlemm’s Canal MIGS?
Paul Petrakos, DO, MS
I. Paul Singh, MD
What’s New in Glaucoma Therapy?
Justin Schweitzer, OD, FAAO
Sarah H. Van Tassel, MD
Evolving Strategies for Sustained-Release Glaucoma Treatments
Loading...
We're glad to see you're enjoying Prova Education… but how about a more personalized experience?
Press cancel to remain on Prova Education. Press the link below or the continue button to keep going.